Skip navigation
>»
RSS feed for this page
Know something we don't? Submit a conference announcement
Choose Category:

Infectious Diseases meetings & conferences

31 meetings & conferences listed in Infectious Diseases 

American Mosquito Control Association 81st Annual Meeting
United States
Louisiana
03/29/2015

American Mosquito Control Association 81st Annual Meeting

March 29 - April 2, 2015 New Orleans, Louisiana

The AMCA Annual Meeting is the premier education and networking event for researchers, educators, vector control professionals, industry representatives, and students in mosquito control. Every year since 1935, hundreds gather to hear the latest research, share ideas, and form collaborations. Our educational sessions and exhibit hall help to put attendees on the cutting-edge of this ever-expanding field!

We invite you to join us in New Orleans, whether it's your first meeting or your twenty-first! There is something to be gained by attendees of all levels of experience.

Contact Information

All AMCA 81st Annual Meeting program and logistics questions should be directed to Shay McClain at meetings@mosquito.org or (856) 380-6897.

Physician, Physician Researcher, Public Health Expert, Public Health Worker, Public Servant, Scientist
HPV 2015-- 30th International Papillomavirus Conference & Clinical and Public Health Workshops
Portugal
09/17/2015

HPV 2015-- 30th International Papillomavirus Conference & Clinical and Public Health Workshops

September 17-21, 2015 Lisbon, Portugal

Join us for the 30th International Papillomavirus Conference & Clinical and Public Health Workshops (HPV 2015) that will be held September 17-21 in Lisbon, Portugal. This year we will focus on HPV and Globalization, exploring new worlds in research as well as new proposals to reduce inequities in global health.

HPV gathers researchers, clinicians and other health professionals to share and exchange research regarding the epidemiology of HPV, virus vaccines, cervical cancer prevention and other papillomavirus associated diseases. We host an international forum that enables the exchange of knowledge between the research and clinical communities showcasing the latest advances in science and practice through state of the art oral and poster presentations.

Epidemiologist, Gynecologist, Physician Researcher, Public Health Expert, Public Health Worker, Public Servant, Virologist
The Arthropod Vector: The Controller of Transmission
United States
New Mexico
05/12/2015

The Arthropod Vector: The Controller of Transmission

May 12—17, 2015 Taos, New Mexico

Vector borne diseases impose a disproportionate economic burden on developing countries. However, most research on the prevention of transmission of the pathogens that cause them has focused on the mammalian immune response to the pathogens, ignoring the contribution of the biting arthropod vector. The Scientific Program proposed represents breadth and depth of current hot topics in vector biology. Vector innate immunity studies have been ongoing for about a decade and this field has matured and helped our understanding of the complex interactions between pathogens and vectors. The vector microbiome represents a novel, nascent area of research with great promise for the development of novel prevention and control approaches. Vector saliva has been known to contain powerful biomolecules, but it is only recently that we have begun to understand the translational potential of these molecules. Furthermore, vectors also ingest various bioactive factors of human origin which affect the development and survival of pathogens within the vector.

Purpose of the meeting:

• Integrate the multiple levels of influence on disease transmission by the arthropod vector under a single meeting.

• Access the extensive knowledge of innate immunity gained in Drosophila to inform vector studies, incorporate the dynamic and cutting edge research on the role of the microbiome, and explore how the biologically and immunologically active components of saliva influence transmission.

• Bring together researchers from multiple scientific areas relevant to vector-borne pathogen transmission and promote the discussion and exploration of multidisciplinary approaches and collaborations to address the challenge of arthropod-transmitted diseases.

• Translate immunological and microbiological insights into new approaches for combating vector-borne diseases, including manipulation of the microbiome and identification of novel, non-traditional vaccine targets (e.g., arthropod saliva proteins).

Immunologist, Physician Researcher, Public Health Expert, Virologist
Mechanisms of HIV Persistence: Implications for a Cure
United States
Massachusetts
04/26/2015

Mechanisms of HIV Persistence: Implications for a Cure

April 26—May 1, 2015 Boston, Massachusetts

Despite long-term control of HIV replication with cART, HIV persists as silenced integrated DNA in memory CD4 T cells, and possibly in other cellular reservoirs, including naïve cells and macrophages. Low level replenishment of the reservoir via limited cycles of replication, may also contribute to persistence, at least in some patients. Curing HIV infection will only occur if these barriers are reversed, or if host capacity to control HIV indefinitely is improved. A number of promising interventions which might reverse latent infection have been identified, and proof that such drugs affect HIV transcription in vivo provided in pilot clinical trials. The observation that few patients treated during primary infection control durably replication-competent HIV after interrupting therapy suggests host responses might be manipulated, leading to a functional cure. The path forward will require a detailed understanding of the mechanisms of viral latency which could lead to the identification of new drugs, and a better knowledge of the plasticity and dynamics of the main HIV cell reservoirs: CD4 T cells and macrophages. The role of the tissue microenvironment has to be underlined with the major help of non-human primate models. At the 2015 Keystone Symposia meeting on Mechanisms of HIV Persistence: Implications for a Cure, experts from both within and outside the HIV field will present findings from recent advances on immune mechanisms and therapeutic strategies which could lead to HIV cure.

Immunologist, Physician Researcher, Virologist
Innate Immunity and Determinants of Microbial Pathogenesis
United States
California
04/19/2015

Innate Immunity and Determinants of Microbial Pathogenesis

Joint with the meeting on Mechanisms of Pro-Inflammatory Diseases

April 19—24, 2015 Olympic Valley, California

Registered attendees of one meeting in a joint pair may participate in sessions of the other, pending space availability.

In 2000, a Keystone Symposia meeting on Determinants of Immune Defense Against Microbial Infections was held, and received outstanding reviews. At the time, this meeting met an unmet scientific need—a small interactive gathering for those interested in microbial immunology from the perspective of gaining insight into basic immune mechanisms, understanding microbial pathogenesis and developing preventative and therapeutic interventions. We have been urged by some of the more than 300 attendees of that meeting to repeat and update this meeting, as the topic is ever more timely with the emergence of drug resistant organisms, the advances in immunology, the insights gained from understanding the normal and disease microbiome, and the rapid technologic advances including high throughput sequencing and robotics. This meeting will focus on innate and adaptive immunity to microbial infections. Microbial infections pose major health problems worldwide, but also represent extraordinary models to study immune regulation. Important advances in immunology have been made in recent years and have led to a new understanding of host-pathogen interactions. This conference will explore the interaction of the innate and adaptive immune response in the host defense against microbial infection. Topics include: Innate Immunity, Innate Immune Sensing and Consequences in Microbial Infection, Innate Immunity in Inflammation and Disease, Adaptive Immunity, Regulation of Immune Responses, Immune Mechanisms in Inflammation and Infection, Intervention/Vaccines, and Targets for Immunotherapy. This meeting aims to bring together immunologists who study basic mechanisms and those that study infectious agents to formulate new strategies to control some of the world’s most deadly diseases.

Immunologist, Microbiologist, Physician Researcher, Public Health Expert, Virologist
7th International Conference on Health Issues in Arab Communities
Oman
03/01/2015

7th International Conference on Health Issues in Arab Communities

March 1-7, 2015 Muscat, Oman

Since its inception in 1989, the ACCESS Community Health & Research Center has become the largest and most comprehensive Arab community-based health and mental health center in North America.

About the Arab Health Conference

Arab Americans share a cultural and linguistic heritage, as well as common risk factors and disease patterns tied to their Arab ancestry. As is the case for other immigrant groups, when Arab populations settle in areas such as the United States, Canada, Australia and Europe, they experience socioeconomic transformations, changes in lifestyle, and educational factors that lead to a change in the prevalence of disease, marked by the emergence of chronic illnesses.

In collaboration with The Ministry of Health of the Sultanate of Oman and our national and  international partners, the upcoming conference adds an international perspective by convening local, national and international medical practitioners and public health and mental health professionals at a scientific forum dedicated to addressing the social determinants of health, the impact of genetics on health and chronic disease, and issues associated with quality of health care, ethics and palliative care in Arab communities around the world.

Community Activist, Health Services Researcher, Nurse, Nurse Researcher, Physician, Physician Researcher, Policy Analyst, Public Health Expert, Public Health Worker, Public Servant
8th Academic and Health Policy Conference on Correctional Health
United States
Massachusetts
03/19/2015

8th Academic and Health Policy Conference on Correctional Health

March 19-20, 2015 Boston, Massachusetts

The Correctional Health Conference provides a forum for researchers, clinicians, administrators, educators, policy makers, and grant funding leaders to network, share evidence, and learn about emerging research and relevant policy updates in the field of correctional health care.

This year's conference theme is Implementation Science.

Community Activist, Nurse, Nurse Researcher, Physician, Physician Researcher, Policy Analyst, Public Health Expert, Public Health Worker, Public Servant, Social Worker
HIV Drug Therapy in the Americas 2015
Mexico
04/16/2015

HIV Drug Therapy in the Americas 2015

16-18 April 2015 Mexico City, Mexico

Pharmacologist, Physician Researcher, Public Health Expert
25th European Congress of Clinical Microbiology and Infectious Diseases
Denmark
04/25/2015

25th European Congress of Clinical Microbiology and Infectious Diseases

April 25-28, 2015 Copenhagen, Denmark

The 25th European Congress of Clinical Microbiology and Infectious Diseases will be held in Copenhagen, Denmark. The steady growth in importance of ECCMID has made it our mission to maintain or even increase the excellence of this congress. To achieve this goal the Program Committee will prepare a series of keynote lectures, symposium, educational workshops and meet-the-expert sessions on parallel tracks, covering the entire field of infectious diseases and clinical microbiology.

Microbiologist, Physician Researcher, Public Health Expert, Public Health Worker
HIV Vaccines
Canada
03/22/2015

HIV Vaccines

Joint with the meeting on The Golden Anniversary of B Cell Discovery

March 22—27, 2015 Banff, Alberta, Canada

Registered attendees of one meeting in a joint pair may participate in sessions of the other, pending space availability.

As the 30th anniversary of the discovery of HIV has come and gone, HIV remains a catastrophic public health concern, with an estimated global prevalence of 34 million HIV-infected persons. Despite the remarkable advances in the development of several biomedical interventions for the prevention of HIV, the importance of developing an effective HIV vaccine has been recognized by a wide spectrum of the scientific community and civil society. Important milestones for the HIV vaccine field were the demonstration that a vaccine regimen could reduce HIV acquisition and the identification of binding IgG envelope (env) antibodies as potential correlates of protection from HIV acquisition. However, broad neutralizing antibodies (bNAbs) are thought to be the main mechanism of protection of the currently available effective vaccines. The present meeting will address the major scientific gaps in the the generation of env bNAbs. The major goals of the meeting include: 1) To understand the development of bNAbs in natural infections and following vaccination; 2) To determine predictors of response to vaccines; 3) To review the advances in envelope immunogen design; 4) The therapeutic use of bNAbs; 5) The application of novel technologies to monitor the immune response; and 6) The development of therapeutic strategies aimed to functional HIV cure. The meeting will bring together interdisciplinary groups with outstanding expertise in B- and T-cell biology, structural biology, vaccinology and clinical science. It will therefore provide to the attendees how innovative basic observations from the bench side may translate into the clinical development of vaccines and therapeutic interventions.

Physician Researcher, Virologist

234next